Skip to main content
Premium Trial:

Request an Annual Quote

BioForce Nanosciences, Hitachi Software Engineering

Premium

BioForce Nanosciences of Ames, Iowa, has received US Patent No. 7,008,769, "Nanoscale molecular arrayer." The patent claims an apparatus for the formation of an array that includes one or more deposition domains comprised of one or more deposition materials. The present invention may include an X, Y controller, an X, Y translation stage, a loading substrate, a deposition substrate, a Z controller, and a deposition probe, the patent's abstract states. A computer system that controls all of the relative positions of each of the components, and a humidity control system that is used to transfer the deposition material between the loading substrate, the deposition probe, and the deposition substrate, are also claimed.


Hitachi Software Engineering of Kanagawa, Japan, has received US Patent No. 7,010,430, "Method for displaying gene experiment data." The patent describes a method for creating a visual display that is useful for comparing expression data of genes from two experiments based on expression data of one sample common to both experiments. According to the patent's abstract, in order to compare data of expression levels obtained from different experiments, each using two types of samples, three types of expression levels are displayed in three dimensions as mediated by the data of the common sample used in both experiments. Expression level data for samples A and B and expression level data for samples A and C are then combined and converted into single three-dimensional data and displayed as points inside a sphere, the abstract continues. A clustering analysis is performed based on the distributed points to visually understand the expression state of genes for the three types of samples. The expression-level data displayed as points inside or on the sphere can also be linked as a line or a curve for each gene or for each gene group resulting from the clustering analysis, to visually understand the changes of expression states with time.

 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.